Frankenfield Christopher James

Insider profile

Frankenfield Christopher James's trades of Xilio Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-01-05 2026-01-02 PlS Planned sale
3,996 -43.9%
87.84
US$1,975,684
3,996 -43.9% 87.84 US$1,975,684
2025-01-03 2025-01-02 PlS Planned sale
91,890 +22.4%
456.38
US$784,019
91,890 +22.4% 456.38 US$784,019